Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Figure 6 | BMC Immunology

Figure 6

From: Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters

Figure 6

T-cell proliferation results in hamsters immunized with the candidate HIV-1 gp120 vaccines. Splenocytes were cultured and stimulated with 10 μg/ml proteins of (6A): HIV-1 gp120 subtype B (MN strain), (6B): HIV-1 gp120 subtype B (SF162 strain), (6C): HIV-1 gp120 subtype C (96ZM651 strain), and (6D): HIV-1 gp120 subtype A/E (93TH975 strain). Two days later, 3H-thymidine was added and after 18 h the incorporated radioactivity was measured in harvested splenocytes. The stimulation index (SI) ± S.E. is shown for each group. Symbol * indicates a significant difference between group D with groups B and C (p ≤ 0.05).

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us